![]() |
![]() |
![]() |
Objective of the Issue
The Company proposes to utilise the Net Proceeds towards funding the following objects:
Particulars | Estimated Amount |
Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by the Company. | 310 Crore |
Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes | — |
IPO Details, Price, Market Lot
Rubicon Research IPO Details | |
IPO Open Date | 9 October 2025 |
IPO Close Date | 13 October 2025 |
IPO Issue Size | 2,84,02,040 Shares (Aggregating up to ₹1,377.50 Cr) |
Fresh Issue | 1,03,09,278 Shares (Aggregating up to ₹500.00 Cr) |
Offer for Sale | 1,80,92,762 Shares (Aggregating up to ₹877.50 Cr) |
Retail Portion | Not more than 10% of the net offer |
NII Portion | Not more than 15% of the net offer |
QIB Portion | Not less than 75% of the net offer |
Listing At | NSE, BSE |
Rubicon Research IPO Price | |
Face Value | ₹1 Per Share |
IPO Price Band | ₹461 to ₹485 Per Share |
IPO Issue Type | Book Built Issue IPO |
Rubicon Research IPO Time Table (Tentative) | |
IPO Open Date | 9 October 2025 |
IPO Close Date | 13 October 2025 |
Basis of Allotment Date | 14 October 2025 |
Initiation of Refunds | 15 October 2025 |
Credit of Share to Demat Account | 15 October 2025 |
IPO Listing Date | 16 October 2025 |
Company Promotor & Promotor’s Holding | |
Pratibha Pilgaonkar, Sudhir Dhirendra Pilgaonkar, Parag Suganchand Sancheti, Surabhi Parag Sancheti, Sumant Sudhir Pilgaonkar and General Atlantic Singapore RR Pte Ltd are promoters of the company. | |
Pre Issue Promotor Holding | 77.67% |
Post Issue Promotor Holding | |
Company’s Contact & Address | |
Rubicon Research Limited MedOne House, B-75, Road No. 33, Wagle Estate, Thane, Maharashtra, 400604 Phone: 022 61414000 Email: investors@rubicon.co.in Website: https://www.rubicon.co.in/ |
|
IPO Registrar, Lead Manager, Prospectus | |
Rubicon Research IPO Prospectus | |
Rubicon Research IPO Registrar | |
MUFG Intime India Pvt Limited | |
Rubicon Research IPO Lead Manager | |
|
Rubicon Research IPO
Number of Shares Per Lot = 30 Shares | |||
Application | Lot(s) | Shares | Amount |
Retail (Minimum) | 1 | 30 | ₹14,550 |
Retail (Maximum) | 13 | 390 | ₹1,89,150 |
S-HNI (Minimum) | 14 | 420 | ₹2,03,700 |
S-HNI (Maximum) | 68 | 2,040 | ₹9,89,400 |
B-HNI (Minimum) | 69 | 2,070 | ₹10,03,950 |
Number of Shares Per Lot = 30 Shares | |||
Application | Lot(s) | Shares | Amount |
Retail (Min) | 1 | 30 | ₹14,550 |
Retail (Max) | 13 | 390 | ₹1,89,150 |
S-HNI (Min) | 14 | 420 | ₹2,03,700 |
S-HNI (Max) | 68 | 2,040 | ₹9,89,400 |
B-HNI (Min) | 69 | 2,070 | ₹10,03,950 |
Financial Report
Period Ended |
Assets (₹ in Crore) |
Revenue (₹ in Crore) |
P A T (₹ in Crore) |
Net Worth (₹ in Crore) |
Borrowings (₹ in Crore) |
30 June 2025 | 1,647.60 | 356.95 | 43.30 | 593.67 | 495.78 |
31 March 2025 | 1,451.43 | 1,296.22 | 134.36 | 540.98 | 393.17 |
31 March 2024 | 1,109.49 | 872.39 | 91.01 | 385.00 | 396.41 |
31 March 2023 | 749.70 | 419.00 | -16.89 | 286.38 | 317.91 |
Period Ended | 30 June 2025 | 31 March 2025 | 31 March 2024 | 31 March 2023 |
Assets | 1,647.60 | 1,451.43 | 1,109.49 | 749.70 |
Revenue | 356.95 | 1,296.22 | 872.39 | 419.00 |
P A T | 43.30 | 134.36 | 91.01 | -16.89 |
Net Worth | 593.67 | 540.98 | 385.00 | 286.38 |
Borrowings | 495.78 | 393.17 | 396.41 | 317.91 |
Amount in ₹ Corre |